Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1999 1
2001 1
2008 1
2009 7
2010 6
2011 2
2012 6
2013 5
2014 5
2015 5
2016 6
2017 17
2018 16
2019 10
2020 16
2021 14
2022 12
2023 17
2024 8
2025 15
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kamiya a[au] (688 results)?
Adult Chickenpox.
Yokota K, Tamiya A, Sahara T, Nakamura-Uchiyama F. Yokota K, et al. Among authors: tamiya a. Intern Med. 2020 Aug 1;59(15):1923. doi: 10.2169/internalmedicine.4478-20. Epub 2020 Apr 23. Intern Med. 2020. PMID: 32321895 Free PMC article. No abstract available.
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.
Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, Hirai S, Nakamura R, Morimoto K, Furuya N, Arai S, Goto Y, Sakata Y, Nishino K, Tsuchiya M, Tamiya A, Saito G, Muto S, Takeda T, Date K, Fujisaka Y, Watanabe S, Fujimoto D, Uehara H, Horinaka M, Sakai T, Yano S, Tokuda S, Takayama K. Katayama Y, et al. Among authors: tamiya a. Clin Cancer Res. 2025 Mar 17;31(6):1127-1141. doi: 10.1158/1078-0432.CCR-24-1762. Clin Cancer Res. 2025. PMID: 39495173
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Ishihara M, Kawamura T, Namba Y, Takeyasu Y, Hasegawa Y, Sato Y, Negi Y, Oba T, Sumi T, Hirata H, Funabashi H, Oya Y, Kikuchi H, Katsurada N, Nakatani T, Tanimura K, Nakagawa T, Takeda N, Asami T, Honjo O, Nagashima H, Yamaura T, Hata N, Kitazono M, Nishioka N, Tamiya A, Sakamori Y, Shigaki R, Kaira K, Honda R, Matsui T, Suzuki E, Ito K, Otsuka K, Takase N, Murakami Y, Matsuno K, Inoue S, Kisohara A, Kusumoto S, Aoshima H, Kakizaki Y, Kubo A, Hata A, Ishikawa N, Hamai K, Kanaji N, Misumi T, Matsutani N, Seki N. Ishihara M, et al. Among authors: tamiya a. Ther Adv Med Oncol. 2025 Jun 16;17:17588359251344010. doi: 10.1177/17588359251344010. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40535732 Free PMC article.
Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study.
Tsukaguchi A, Matsumoto K, Tamiya A, Tamiya M, Mori M, Suzuki H, Shiroyama T, Miyazaki A, Komuta K, Mihashi Y, Yamauchi K, Kanaoka K, Kuge T, Kinehara Y, Azuma K, Niki T, Moritomo K, Takeda Y, Kumanogoh A. Tsukaguchi A, et al. Among authors: tamiya a. Eur J Cancer. 2025 Oct 1;228:115748. doi: 10.1016/j.ejca.2025.115748. Epub 2025 Aug 30. Eur J Cancer. 2025. PMID: 40902339
Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.
Tamiya A, Mizumori Y, Osuga M, Isa SI, Taniguchi Y, Nakamura K, Harada D, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y. Tamiya A, et al. Cancer Med. 2025 Apr;14(7):e70861. doi: 10.1002/cam4.70861. Cancer Med. 2025. PMID: 40186430 Free PMC article.
Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer.
Matsumoto K, Noda Y, Hachiya K, Muramatsu F, Okamoto N, Jia W, Shiroyama T, Mori M, Tamiya M, Kinehara Y, Tamiya A, Shimizu S, Suzuki H, Ueno K, Niki T, Tetsumoto S, Morimura O, Osa A, Minami T, Nojima S, Takeda Y, Shintani Y, Kumanogoh A, Takakura N. Matsumoto K, et al. Among authors: tamiya a. Cancer Cell Int. 2026 Jan 6;26(1):65. doi: 10.1186/s12935-025-04161-7. Cancer Cell Int. 2026. PMID: 41495736 Free PMC article.
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study.
Shiono A, Imai H, Kaira K, Abe T, Sato Y, Yamamoto K, Watanabe H, Tsuchiya-Kawano Y, Tamiya A, Osaki T, Yanagitani N, Tanzawa S, Sumi T, Yoshimine K, Matsui Y, Endo S, Shibata K, Takemoto S, Miura Y, Nagai Y, Nakagawa J, Tsuda T, Kagamu H. Shiono A, et al. Among authors: tamiya a. Thorac Cancer. 2025 Jul;16(13):e70118. doi: 10.1111/1759-7714.70118. Thorac Cancer. 2025. PMID: 40583736 Free PMC article.
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC.
Kanaoka K, Matsumoto K, Shiroyama T, Tsukaguchi A, Shoshihara N, Moritomo K, Kinehara Y, Mihashi Y, Kuge T, Yoneda M, Kato S, Yamauchi K, Machiyama H, Nishikawa Y, Morimura O, Miyazaki A, Komuta K, Azuma K, Tanaka S, Niki T, Osa A, Tamiya A, Tamiya M, Suzuki H, Mori M, Takeda Y, Kumanogoh A. Kanaoka K, et al. Among authors: tamiya a. JTO Clin Res Rep. 2025 Aug 21;6(11):100891. doi: 10.1016/j.jtocrr.2025.100891. eCollection 2025 Nov. JTO Clin Res Rep. 2025. PMID: 41142139 Free PMC article.
149 results